Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Abishek medical devices | 8 | - |
| 2 | Schedule 4 | Abishek medical devices | 8 | - |
Tender Value
₹86,273.22
EMD Value
Exempted
Closing Date
20 Oct 2025, 9:00 amClosed
Inj Human Rabies Immunoglobulin 600 iu per ml 1 ml
Calcium Chloride pttk and aptt reagent 10 into 10 ml
00598CK Prest 6into 2 ml
Betahistine Dihydro Chloride 8 mg Tab
Hemacolour 3 into 100 ml rapid stain for blood smear
Fluticasone Furote 100mcg plus Umeclidinium 62 point 5 mcg
8452803
GEM/2025/B/6772370
Two Packet Bid
Inj Human Rabies Immunoglobulin 600 iu per ml 1 ml
30 days
Telangana; Hyderabad
Item wise evaluation
BOQ
8 documents required · 8 mandatory
1 yrs
₹31
₹1 L
50%
Exempted
22 Oct 2025
10 Oct 2025
20 Oct 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Inj Human Rabies Immunoglobulin 600 iu per ml 1 ml | 40 | Vial | Hyderabad | 30 |
| 2 | Calcium Chloride pttk and aptt reagent 10 into 10 ml | 2 | No | Hyderabad | 30 |
| 3 | 00598CK Prest 6into 2 ml | 1 | Pack | Hyderabad | 30 |
| 4 | Betahistine Dihydro Chloride 8 mg Tab | 11,700 | No | Hyderabad | 30 |
| 5 | Hemacolour 3 into 100 ml rapid stain for blood smear | 1 | Pack | Hyderabad | 30 |
| 6 | Fluticasone Furote 100mcg plus Umeclidinium 62 point 5 mcg | 3 | No | Hyderabad | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8452803.pdf
GEM_BID
document_76_2025-10-09-16-13-51_16b62b08077961b2a0c4c07c34f4f74d.pdf
BOQ
27_boq_item_sample_file_2025-10-09-16-13-51_f05898b3ac7324b8aee5e99c5c72bfad.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .